Programming - Hypertension Scientific Sessions

7:30 a.m.
American Heart Association President-Elect Remarks
Svati H. Shah, MD, MS, MHS, FAHA

7:45 a.m.
Welcome Remarks
Jane F. Reckelhoff, PhD, FAHA | Chair, Council on Hypertension
Steven D. Crowley, MD | Chair, Hypertension 2026 Scientific Sessions Program Committee

8:00 a.m.
Metabolic Reprogramming via HIF-1α to Confront Kidney and Cardiovascular Disease
Volker Haase, MD

8:30 a.m.
HIF-2α inhibition and Pheochromocytoma/Paraganglioma
Camilo Jimenez Vasquez, MD

9:00 a.m.
Recent Clinical Trials
Jamie Dwyer, MD

9:30 a.m.
Mechanisms for disrupting aldosterone signals to afford protection in hypertension and CVD
David Ellison, MD

Volker Haase, MD
Vanderbilt University Medical Center

Camilo Jimenez Vasquez, MD
University of Texas MD Anderson Cancer Center

Speakers:
Gianfranco Parati, MD – Professor of Cardiovascular Medicine, University of Milano-Bicocca & Istituto Auxologico Italiano
Ziad Zoghby, MD, MBA, FACP – Associate Professor of Medicine at Mayo Clinic
Maria Carolina Delgado-Lelievre, MD – Founder & Director, Comprehensive Hypertension Center at University of Miami
Elias G. Hellou, MD – Invasive Cardiologist & Research Collaborator, Mayo Clinic

This session brings together a distinguished panel of leading clinical researchers and frontline physicians for a compelling discussion on optimizing hypertension management using actionable 24-hour BP data. The panel will explore the clinical validation and real-world utility of cuffless ABPM, share actionable strategies for treatment optimization, and provide an exclusive first look at new clinical data from a 600-patient hypertensive cohort.

11:00
Intestinal Immune Cell Trafficking and Salt
Nicola Wilck, MD

01
11:30
GLP-1/GIP Receptor Agonism Lowers Blood Pressure and Decreases Disease Activity in an Experimental Model of Systemic Lupus Erythem
Erin Taylor

02
11:45
Central Galantamine Administration Lowers Blood Pressure and Reduces Brainstem and Renal Inflammation in Systemic Lupus Erythematosus
Keisa Mathis

11:00
Invited Speaker: Tackling Resistant Hypertension: Evidence-Based Strategies
Naomi DL Fisher, MD

03
11:30
Persistent Apparent Treatment-Resistant Hypertension and Cardiovascular Risk in the Jackson Heart Study
Lama Ghazi

04
11:45
Characteristics Associated with Endogenous Hypercortisolism in Individuals with Resistant Hypertension and Cardiovascular Disorders: Analyses from the MOMENTUM Study
Omar Al Dhaybi

05
11:00
Effectiveness of Implementation Strategies for Remote Blood Pressure Monitoring in Safety Net Primary Care Clinics: Main Results from the REACH-SNS RCT
Courtney Lyles

06
11:15
Effect of DASH Groceries on Blood Pressure by Hypertension Severity or Treatment Status: Results from the GoFresh and GoFreshRx Trials
Samantha Chin

07
11:30 AM
Antihypertensive Medication Intensification in Pharmacist-Led versus Primary Care-Based Management in a Safety-Net Health System
Valy Fontil

08
11:45
Efficacy and Safety of the Selective Aldosterone Synthase Inhibitor Lorundrostat in Moderate-to-Severe Obstructive Sleep Apnea and Hypertension: Explore-OSA Randomized Crossover Trial
Reena Mehra

Speakers:
Iliana S. Hurtado Rendón MD, FACC
Maria Carolina Delgado-Lelievre, MD
Dr. Florian Rader, MD, MSc

2:00
Imaging macula densa function in blood pressure regulation
Janos Peti-Peterdi, MD, PhD

2:30
The macula densa’s role in mechanisms of AKI and resulting CKD
Ruisheng Liu, MD, PhD

09
3:30
The Case for Screening: Aldosterone-Renin Testing is Associated with Lower Mortality and Cardiovascular Events in Resistant Hypertension
Tayyaba Saleem

10
3:45
Intercalated Cell Cyclooxygenase-2 Restrains Aldosterone-Induced Hypertension, Volume Expansion, and Potassium Loss
Amir Aalami

11
4:00
Female Mice Are Resistant to Angiotensin II-Induced Trained Immunity and Atheroprogression
Emma Hope

12
4:15
CD4+ T Cell-Targeted Nanoparticle Silencing of ROCK2 Attenuates Angiotensin II-Induced Hypertensive Cardiorenal Injury Independent of Blood Pressure
Daniel Fehrenbach

13
4:30
Time of Day Contributes to the CXCR2 Dependence of Angiotensin II-Induced Hypertension
Lance Benson

14
4:45 PM
Microglial ACE2 as a Central Link Between Hypertension and Type 2 Diabetes
Uma Priya Mohan

15
5:00
Chronic RAAS Suppression Drives Hypoxic Vascular Remodeling and Reveals Urinary Biomarkers of Silent Kidney Injury
Lucas Almeida

16
5:15
The Hidden Cardiotoxic Toll of Aldosterone Excess: A National Inpatient Comparison of Primary Aldosteronism vs. Essential Hypertension
Nava Sharma

17
3:30
The Sex Paradox in Hypertension: Higher Prevalence and Cardiovascular Mortality but Lower Treatment Receipt in Men
Kwabena Odei-Kumi

18
3:45
Endothelin-1 Signaling in Dendritic Cells Promotes Hypertension and Arterial Stiffness in a Sex-Dependent Manner
Abigail Brooks

19
4:00
Renin in the Nucleus Ambiguus Differentially Regulates Autonomic Function in Male and Female Mice
Kathren Kaminski

20
4:15
Renal Aromatase Activity Evokes Female-Specific Natriuresis and Blood Pressure Regulation
Frank Kiyimba

21
4:30
Protective Role of STAT3 Inhibition in Androgen-Induced Hypertension in Polyendocrine Metabolic Ovarian Syndrome
Samar Rezq

22
4:45
Menopausal Status-Specific Associations Among Akkermansia muciniphila, Gut Dysbiosis, and Blood Pressure
Tania Akter Jhuma

23
5:00
High Leptin Pregnancy Causes Male Specific Hypertension, Blood Pressure Variability and Circadian Disruption in Offspring of Preeclampsia Mouse Model
Mona Elgazzaz

24
5:15
Sex Differences in the Association Between SVEP1 and Blood Pressure: Evidence from the SALTY Trial, All of Us, and UK Biobank
Mahmoud Hamieh

3:30
Unlocking Physiologic Signals: What Waveforms Reveal Beyond Blood Pressure
Rama Mukkamala, PhD

3:45
Smartwatches and Wearables: Consumer Tools for Hypertension Detection
Dean Picone, PhD

4:00
Navigating the FDA: Validation and Approval for Novel BP Measurement Devices
Kimberly Crowley

4:15
Panel discussion with Q and A
Panelists: Hae-Young Lee, MD; Jordana B. Cohen, MD, MSCE; Christine Chen, MD; Ziad Zoghby, MD, MBA, FACP

4:30
Mining the EHR: Can We Identify Sub-phenotypes of Primary Hypertension?
Jaclyn Hall, PhD

4:45
Predicting Pediatric Hypertension: AI for Early Detection and Treatment
Derek Ng, PhD, ScM

5:00
Implementing AI to Improve Blood Pressure Management
Tina Ann Thompson, MD

5:15
Panel discussion with Q and A
Panelists: Paul Drawz, MD, MHS, MS and Gabriel Tajeu, DrPH, MPH

Managing People and Finances
Curt Sigmund, PhD, FAHA, and Thu Le, MD, FAHA

Building Collaborations
Babbette LaMarca, PhD, and Jennifer Pollock, PhD

Alternative Funding Sources
Uta Erdbrüegger, MD and Paul Welling, MD

Remaining Scientifically Relevant
Mingyu Liang, MB, PhD, and Alicia McDonough, PhD, FAHA

8:00
Basic and immune mechanisms of cognitive impairment in hypertension
Daniela Carnevale, PhD

8:30
Cerebral small vessel disease and dementia in human hypertension
Rebecca Gottesman, MD, PhD

Identifying patients who warrant screening for hormonally-driven hypertension in different clinical settings
Adina Turcu, MD, MS

How should we currently be thinking about subclinical primary aldosteronism and cortisol excess?
Greg Hundemer, MD, MPH

The current state of confirmatory testing and detecting lateralization in primary aldosteronism
Alexander Leung, MPH, MD, FRCPC

Genetic manifestations of hyperaldosteronism and hypercortisolism
Ashima Gulati, MD, PhD

Stephanie Watts Award Finalist Presentations
Mohammad Saleem, PhD
Swati Sharma, PhD

Established Investigator Award for Clinical Hypertension Lecture
Annet Kirabo, MSc, PhD, FAHA

Harry Goldblatt Award for New Investigators
Monica Santisteban, PhD

Overview of New Cardiovascular-Kidney-Metabolic Syndrome Guideline
Chiadi Ndumele, MD, PhD, MS, FAHA

Kidney in Cardiovascular-Kidney-Metabolic Syndrome
Janani Rangaswami, MD, FAHA

Risk assessment in Cardiovascular-Kidney-Metabolic Syndrome
Sadiya S. Khan, MD, MSc, FAHA

Holistic Interdisciplinary Approach to Cardiovascular-Kidney-Metabolic Syndrome
Tiffany M. Powell, MD, MPH, FAHA

Device development: from the oscillometric envelope to FDA clearance
Bruce Friedman, MD

Device prioritization for out-of-office measurement
Carissa Baker Smith, MD, MPH, MS, FAHA

Importance of the cuff for measurement accuracy: challenges with obesity, pediatric populations, and home devices
Speaker: Tammy Brady, MD, PHD

Standardized hypertension management algorithms: measurement, diagnosis, and prescription of SPC
Marc Jaffe, MD

Out-of-office BP integration and remote monitoring implementation
Sharon Rikin, MD, MS

Coverage changes, reimbursement landscape, and billing for home and remote BP
Kate Kirley, MD, MS

Strategy pathways
Hilary Wall, MPH

A young woman with hypokalemia and hypertension
Jehan Zahid Bahrainwala, MD and Vivek Bhalla, MD, Stanford University

Renal denervation for intractable hypertension due to hyperactivation of the sympathetic nervous system
Jacob Stein, MD, NY Presbyterian Brooklyn Methodist Hospital and Debbie L Cohen, MD, University of Pennsylvania

Birth history and its role in development of hypertension
Joseph Flynn, MD, MS

Youth hypertension and long-term CV and cognitive outcomes
Rahul Chanchlani, MD

Arterial characteristics across age continuum
Josh Samuels, MD, MPH

Sex differences in physiology and trajectory of blood pressure across the lifespan
Natalie Ann Bello, MD, MPH

Physiologic and pathologic changes in blood pressure during pregnancy
Janet Catov, PhD, MS

Role of behavioral psychologist: Coaching techniques to help with implementation of traditional and nontraditional lifestyle modifications
Kaushal Amatya, PhD

Role of the dietitian: Practical diet/salt strategies for hypertension management across the lifespan
Kristie Lancaster, PhD

Weight loss strategies with and without GLP-1RAs
Alexa Triot, MD

Gregory Fink, PHD, FAHA

Giuseppe Lembo, MD, PhD

The effects of time-restricted feeding on cardiovascular disease in obesity
Jennifer Pollock, PhD

Key clinical research: Role of Circadian Regulation in Cardiometabolic Health and Disease Risk
Kristen Knutson, PhD

BMAL1, aldosterone, and sex differences in blood pressure regulation
Michelle Gumz, PhD

Renal denervation in complex patients
Jennifer Cluett, MD

Secondary hypertension in pregnancy
Lara Kovell, MD

Resistant hypertension without clear secondary cause
Brian Byrd, MS, MS

Hypertension management among older, frail adults
B. Gwen Windham, MD